Gene · 51744
Papers3,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy. | Cell Commun Signal | 2024 | 38297380 | PubTator, text mining | PubMed |
| Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells. | Cancer Immunol Immunother | 2024 | 38280067 | PubTator, text mining | PubMed |
| The Addition of Atezolizumab to Chemotherapy in Non-Small Cell Lung Cancer: A Trial-Based Review and Meta-Analysis. | World J Oncol | 2024 | 38274722 | PubTator, text mining | PubMed |
| The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia. | Cell Commun Signal | 2024 | 38254135 | PubTator, text mining | PubMed |
| PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer. | Sci Rep | 2024 | 38245572 | PubTator, text mining | PubMed |
| PD-1/PD-L1 governed cross-talk of exhausted CD8+ T and memory B cells in systemic lupus erythematosus. | RMD Open | 2024 | 38233074 | PubTator, text mining | PubMed |
| CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma. | PLoS One | 2024 | 38232115 | PubTator, text mining | PubMed |
| Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature. | Heliyon | 2024 | 38226253 | PubTator, text mining | PubMed |
| In-depth analysis of prognostic markers associated with the tumor immune microenvironment and genetic mutations in breast cancer based on an NK cell-related risk model. | Heliyon | 2024 | 38226219 | PubTator, text mining | PubMed |
| Harnessing natural killer cell effector function against cancer. | Immunother Adv | 2024 | 38223411 | PubTator, text mining | PubMed |
| Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside. | Cell Death Dis | 2024 | 38221520 | PubTator, text mining | PubMed |
| Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies. | J Biomed Sci | 2024 | 38217016 | PubTator, text mining | PubMed |
| Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications. | Virol J | 2024 | 38216935 | PubTator, text mining | PubMed |
| Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis. | J Cancer | 2024 | 38213717 | PubTator, text mining | PubMed |
| Engineering approaches for innate immune-mediated tumor microenvironment remodeling. | Immunooncol Technol | 2024 | 38213392 | PubTator, text mining | PubMed |
| Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer. | BMC Genomics | 2024 | 38212708 | PubTator, text mining | PubMed |
| Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma. | Aging (Albany NY) | 2024 | 38206304 | PubTator, text mining | PubMed |
| Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. | Sci Rep | 2024 | 38184757 | PubTator, text mining | PubMed |
| Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma. | Eur J Med Res | 2024 | 38183155 | PubTator, text mining | PubMed |
| The emerging role of ectodermal neural cortex 1 in cancer. | Sci Rep | 2024 | 38177640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51744/papers?page=9